The latest news for pharma industry insiders.
The importance of expanding your pharma sales forecasting horizon beyond the US. Learn how to effectively navigate country-specific regulatory red flags.
The development of avian influenza vaccines is the main priority amid rising cases in the United States.
Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive officer.
The "E-prescribing Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering. The global e-prescribing market is forecast to grow at a CAGR of 21.87% from 2023 to 2029, reaching a projected US $5.57 Billion by 2029.
The global e-prescribing market report consists of exclusive data on 28 vendors. The market is witnessing rapid growth, driven by international and regional players offering solutions with advanced features like clinical decision support and electronic prior authorization. The market is expected to expand further as new vendors collaborate with established software providers. While the large players dominate, several mid-sized and emerging vendors such as DrFirst, Qualifacts, and Practice Fusion are gaining market traction, especially in niche areas like stand-alone solutions for small practices or private clinics.
Hear from Gwen Volpe RPh, LSSBB, FASHP, Senior Director of Medication Technology at Fresenius Kabi on RFID's potential to revolutionize medication workflows in the hospital setting in a recent piece from
#RFID #FreseniusKabi
Have news you want us to share in Pharma Pulse? Reach out to Editor
